Clinically relevant features in patients with systemic mastocytosis (SM) include the cosmetic burden of lesional skin, mediator-related symptoms, and organ damage resulting from mast cell (MC) infiltration in advanced forms of SM.
Esperion Therapeutics, has announced positive results from a Phase II clinical trial for ETC-1002. This novel small molecule activator of...
OPTI Medical Systems, Inc., a subsidiary of IDEXX Laboratories, Inc. announced that it has received the CE mark certification in the European Union for its OPTI SARS-CoV-2 RT-PCR laboratory test kit for the detection of SARS-CoV-2, the virus that causes COVID-19.
Qiagen announced the immediate launch of its Therascreen PIK3CA RGQ PCR Kit (therascreen PIK3CA Kit) after it received U.S. regulatory...
Blueprint Medicines Corporation announced Ayvakit (avapritinib) data showed high, durable response rates and prolonged overall survival (OS) in patients with advanced systemic mastocytosis (Advanced SM), including SM with an associated hematological neoplasm (SM-AHN)
Delcath Systems, Inc.announced that the FDA has issued a Complete Response Letter (CRL) regarding the New Drug Application (NDA) for...
BGI Genomics announced that its subsidiary BGI Americas Corporation has received authorization under Interim Order from Health Canada to supply its Real-Time Fluorescent RT-PCR Kit for Detecting SARS-CoV-2 in the Canadian market.
Kitov Pharmaceuticals has announced that the Phase III, double-blind, placebo-controlled clinical trial for its leading drug candidate, KIT 302 (celecoxib...